Dynamics of SARS-CoV-2 Variants and Mutations in Central Sweden Between 2023 and 2024 and Their Potential Implications on Monoclonal Antibodies Pemivibart and Sipavibart As PrEP in the Region.

Jonathan Haars, Frans Wallin, Karin Elfving, Anna-Karin Jonsson,Patrik Ellström,Paula Mölling,Johan Lindh, Hong Yin,Martin Sundqvist,René Kaden, Navaneethan Palanisamy,Johan Lennerstrand

Infectious diseases (London, England)（2025）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined